- A target joint was defined as a major joint with ≥3 bleeding episodes over 3 consecutive months
- Target joint resolution was defined as ≤2 spontaneous joint bleeds within 12 months
1.4
Median overall bleeds per year (B-LONG trial)*
(0-3.4)0.9
Median spontaneous bleeds per year (B-LONG trial)*
(0-2.3)0.4
Median joint bleeds per year
(B-LONG trial)*
Overall annualized bleed rate
Median overall ABR was the middle number of all ABRs, when everyone’s ABR was ordered from least to greatest.
Spontaneous annualized bleed rate
Median spontaneous AsBR was the middle number of all spontaneous ABRs, when everyone’s spontaneous ABR was ordered from least to greatest.
Joint annualized bleed rate
Median joint ABR was the middle number of all joint ABRs, when everyone’s joint ABR was ordered from least to greatest.
1
Median overall bleeds per year
(B-YOND trial)‡
0
Median spontaneous bleeds per year
(B-YOND trial)‡
2
Median overall bleeds per year (Kids B-LONG trial)||
(0-3.1)0
Median spontaneous bleeds per year (Kids B-LONG trial)||
(0-1.2)0
Median joint bleeds per year (Kids B-LONG trial)||
(0-1.1)1.2
Median overall bleeds per year (PUPs B-LONG trial)¶
(0-2.5)
(median overall annualized bleed rate)
0
Median spontaneous bleeds per year (PUPs B-LONG trial)¶
(0-0)
(median spontaneous annualized bleed rate)
0
Median traumatic joint bleeds per year (PUPs B-LONG trial)¶
(0-0)
(median traumatic joint annualized bleed rate)
Indication
Important Safety Information